After buying in candidate, Mannkind wraps up phase 1 trial of inhaled lung infection prospect

[cafead]

via MannKind has wrapped up a phase 1 clinical trial of an inhaled formulation of clofazimine, teeing it up to talk to the FDA about advancing the candidate as a treatment for bacterial lung infections.

article source

 

[anonymous]

Mnkd is going nowhere. You cheat and still suck.